HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Patricia Gilleaudeau Selected Research
Patricia Gilleaudeau Research Topics
Disease
13
Psoriasis (Pustulosis Palmaris et Plantaris)
01/2017 - 02/2003
9
Atopic Dermatitis (Atopic Eczema)
01/2022 - 09/2011
6
Inflammation (Inflammations)
01/2021 - 11/2010
3
Hyperplasia
01/2021 - 06/2014
2
Alopecia Areata
10/2022 - 01/2022
2
Alopecia (Baldness)
10/2022 - 01/2022
2
Melanoma (Melanoma, Malignant)
01/2019 - 10/2016
2
Infections
04/2016 - 12/2005
1
Hidradenitis Suppurativa
11/2020
1
Vitamin D Deficiency
01/2017
1
Neoplasm Metastasis (Metastasis)
10/2016
1
Pigmented Nevus (Melanocytic Nevus)
10/2016
1
Wounds and Injuries (Trauma)
04/2016
1
Hypersensitivity (Allergy)
10/2014
1
Necrosis
03/2013
1
Vitiligo
04/2011
1
Skin Neoplasms (Skin Cancer)
09/2010
1
Thrombosis (Thrombus)
03/2010
1
Thrombocytosis (Thrombocythemia)
03/2010
1
Rheumatoid Arthritis
03/2010
1
Autoimmune Diseases (Autoimmune Disease)
06/2007
1
Graft vs Host Disease (Graft-Versus-Host Disease)
06/2007
1
Skin Diseases (Skin Disease)
02/2005
Drug/Important Bio-Agent (IBA)
4
Cytokines
IBA
01/2019 - 04/2012
4
efalizumab (Raptiva)
FDA Link
01/2012 - 10/2004
3
Proteins (Proteins, Gene)
FDA Link
01/2017 - 12/2007
3
Biomarkers (Surrogate Marker)
IBA
06/2014 - 06/2007
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
03/2010 - 12/2005
3
Alefacept (Amevive)
FDA Link
06/2007 - 02/2005
2
dupilumab
IBA
10/2022 - 01/2022
2
Salts
IBA
10/2022 - 01/2022
2
Monoclonal Antibodies
IBA
01/2022 - 01/2018
2
Interleukin-22 (IL-22)
IBA
01/2019 - 01/2018
2
fezakinumab
IBA
01/2019 - 01/2018
2
Interleukin-12 (IL 12)
IBA
01/2017 - 02/2003
2
diphenylcyclopropenone
IBA
10/2016 - 10/2014
2
Cyclosporine (Ciclosporin)
FDA Link
Generic
10/2014 - 06/2014
2
Messenger RNA (mRNA)
IBA
04/2011 - 02/2003
2
Interleukin-17 (Interleukin 17)
IBA
04/2011 - 11/2010
1
Lipocalin-2
IBA
01/2021
1
loricrin
IBA
01/2021
1
MART-1 Antigen
IBA
01/2021
1
S100 Calcium Binding Protein A7
IBA
01/2021
1
Filaggrin Proteins
IBA
01/2021
1
brodalumab
IBA
11/2020
1
Lipids
IBA
01/2017
1
Ustekinumab (CNTO 1275)
FDA Link
01/2017
1
Cholecalciferol (Vitamin D3)
FDA Link
01/2017
1
25-hydroxyvitamin D
IBA
01/2017
1
hydroxide ion
IBA
01/2017
1
Complementary DNA (cDNA)
IBA
10/2016
1
trichohyalin
IBA
10/2016
1
Keratins (Keratin)
IBA
10/2016
1
Pancreatic Ribonuclease (Ribonuclease A)
IBA
10/2016
1
Ribonucleases (Ribonuclease)
IBA
10/2016
1
Petrolatum (Vaseline)
FDA Link
04/2016
1
Steroids
IBA
01/2016
1
Haptens
IBA
10/2014
1
Interleukin-13
IBA
06/2014
1
Elafin
IBA
06/2014
1
Protease Inhibitors (Protease Inhibitor)
IBA
06/2014
1
Tumor Biomarkers (Tumor Markers)
IBA
03/2013
1
TNF-Related Apoptosis-Inducing Ligand
IBA
03/2013
1
Chemokines
IBA
04/2012
1
Inflammasomes
IBA
04/2011
1
15-hydroxyprostaglandin dehydrogenase
IBA
09/2010
1
Hemostatics (Antihemorrhagics)
IBA
03/2010
1
Interleukins
IBA
03/2010
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
12/2007
1
Etanercept (Enbrel)
FDA Link
12/2007
1
Biological Products
IBA
12/2007
1
Immunoglobulins (Immunoglobulin)
IBA
12/2007
1
Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
IBA
12/2005
1
Nitric Oxide (Nitrogen Monoxide)
FDA Link
12/2005
Therapy/Procedure
5
Therapeutics
04/2016 - 02/2003
1
Aftercare (After-Treatment)
10/2022
1
Ambulatory Surgical Procedures (Outpatient Surgery)
04/2016
1
Intradermal Injections
04/2012
1
Phototherapy (Light Therapy)
09/2011
1
Radiotherapy
11/2010
1
Biological Therapy
06/2007
1
Immunotherapy
02/2005